Literature DB >> 4356847

The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research Group.

.   

Abstract

Mesh：

Substances：

Year:  1973        PMID： 4356847

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  43 in total

1.  Dietary lipid and arteriosclerosis.

Authors:  H Kaunitz
Journal:  J Am Oil Chem Soc       Date:  1975-08       Impact factor: 1.849

Review 2.  Osteoporosis in men: are we ready to diagnose and treat?

Authors:  H M Perry; J E Morley
Journal:  Curr Rheumatol Rep       Date:  2001-06       Impact factor: 4.592

Review 3.  Hormone replacement therapy: a time for pause.

Authors:  Salim Yusuf; Sonia Anand
Journal:  CMAJ       Date:  2002-08-20       Impact factor: 8.262

Review 4.  Estrogen therapies, lipids, and the heart disease prevention controversy.

Authors:  Robert H Knopp; Keiko Aikawa; Eleanor A Knopp
Journal:  Curr Cardiol Rep       Date:  2003-11       Impact factor: 2.931

5.  Inhibition of aberrant androgen receptor induction of prostate specific antigen gene expression, cell proliferation and tumor growth by 17α-estradiol in prostate cancer.

Authors:  Yaming Qiao; Lu Wang; Li-Qun Cai; Chen Tan; Julianne Imperato-McGinley; Yuan-Shan Zhu
Journal:  J Urol       Date:  2011-01       Impact factor: 7.450

6.  Jerome Cornfield's Bayesian approach to assessing interim results in clinical trials.

Authors:  James J Schlesselman
Journal:  J R Soc Med       Date:  2016-01       Impact factor: 5.344

7.  The role of estrogen, progesterone and aromatase in human non-small-cell lung cancer.

Authors:  Nadiyah Kazmi; Diana C Márquez-Garbán; Lilia Aivazyan; Nalo Hamilton; Edward B Garon; Lee Goodglick; Richard J Pietras
Journal:  Lung Cancer Manag       Date:  2012-12

Review 8.  [Hypogonadism in the elderly man. Reliable diagnosis and therapy].

Authors:  M Zitzmann; E Nieschlag
Journal:  Internist (Berl)       Date:  2003-10       Impact factor: 0.743

9.  Adherence adjustment in the Coronary Drug Project: A call for better per-protocol effect estimates in randomized trials.

Authors:  Eleanor J Murray; Miguel A Hernán
Journal:  Clin Trials       Date:  2016-03-07       Impact factor: 2.486

Review 10.  Lessons learned from the prospective pravastatin pooling project.

Authors:  Robert P Byington; Frank M Sacks
Journal:  Curr Atheroscler Rep       Date:  2004-09       Impact factor: 5.113
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.